Company Filing History:
1 out of 68 
1 out of 1,186 
1 out of 1,360 
Years Active: 2017
Title: Jean-Philippe Julien: Innovator in HIV Research
Introduction
Jean-Philippe Julien is a prominent inventor based in San Diego, California. He has made significant contributions to the field of HIV research, particularly in the development of novel vaccine candidates. His work focuses on the HIV-1 envelope glycoproteins, which are crucial for advancing immunological studies and vaccine formulations.
Latest Patents
Jean-Philippe Julien holds a patent for his innovative work on HIV-1 envelope glycoproteins. This patent relates to the preparation and purification of immunogenic compositions that can be utilized as vaccine immunogens. The invention aims to facilitate the identification of broad neutralizing antibodies through various biophysical, biochemical, and immunological studies.
Career Highlights
Throughout his career, Julien has been associated with notable organizations such as the International Aids Vaccine Initiative and The Scripps Research Institute. His work at these institutions has been instrumental in advancing research on HIV and developing potential vaccine solutions.
Collaborations
Jean-Philippe Julien has collaborated with esteemed colleagues, including Michael P. Caulfield and Albert Cupo. These partnerships have enhanced the scope and impact of his research in the field of HIV.
Conclusion
Jean-Philippe Julien's contributions to HIV research through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for potential breakthroughs in vaccine development.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.